| 000 | 01080 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250516090628.0 | ||
| 264 | 0 | _c20120508 | |
| 008 | 201205s 0 0 eng d | ||
| 022 | _a1128-3602 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDi Francia, R | |
| 245 | 0 | 0 |
_aGenetic variants influencing fluoropyrimidine based-therapy and available methods to detect them. _h[electronic resource] |
| 260 |
_bEuropean review for medical and pharmacological sciences _cMar 2012 |
||
| 300 |
_a285-98 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xadministration & dosage |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 700 | 1 | _aCimino, L | |
| 700 | 1 | _aBerretta, M | |
| 773 | 0 |
_tEuropean review for medical and pharmacological sciences _gvol. 16 _gno. 3 _gp. 285-98 |
|
| 999 |
_c21728583 _d21728583 |
||